Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VidaCann is a Florida medical cannabis company that cultivates, processes, and dispenses cannabis products through a statewide retail network. The business built a vertically integrated model spanning greenhouse cultivation, processing, analytical laboratory capabilities, product manufacturing, and dispensary operations in Florida. Its product portfolio has included cannabis flower, pre-rolls, vape cartridges, concentrates, tinctures, capsules, and related branded offerings for registered medical marijuana patients. In May 2024, VidaCann was acquired by Planet 13 Holdings and continues operating as part of Planet 13’s Florida platform. For a healthcare analyst, VidaCann is best understood as a commercial-stage medical cannabis operator rather than a traditional biotech drug developer, with revenue driven by regulated retail sales and in-state production assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VidaCann.